Raphaël Wisniewski
Chief Executive Officer at Axonics Europe SAS
Network origin in Raphaël Wisniewski first degree
Entity | Entity type | Industry | |
---|---|---|---|
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France.
94
| Private Company | Investment Managers | 94 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
18
| Public Company | Medical Specialties | 18 |
Public Company | Medical Specialties | 15 | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.
13
| Subsidiary | Medical/Nursing Services | 13 |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom.
12
| Subsidiary | Biotechnology | 12 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.
12
| Holding Company | Biotechnology | 12 |
SoniVie Ltd.
SoniVie Ltd. Medical SpecialtiesHealth Technology SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.
10
| Holding Company | Medical Specialties | 10 |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.
9
| Extinct | Pharmaceuticals: Major | 9 |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Raphaël Wisniewski via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
ESCP Europe Campus Paris | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Université Paris Dauphine-PSL | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Founder Founder Founder | |
ESSEC Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
University College London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
University of Utrecht | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Synacktiv SAS
Synacktiv SAS Information Technology ServicesTechnology Services Synacktiv SAS provides cyber security services. The company is based in Paris, France. The French company was founded in 2012 by Nicolas Collignon, Renaud Feil. Renaud Feil has been the CEO since 2012. | Information Technology Services | Director/Board Member Director/Board Member Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
EM Lyon Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
POXEL | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
N.L.T Spine Ltd.
N.L.T Spine Ltd. Medical SpecialtiesHealth Technology N.L.T Spine Ltd. develops spine surgery instrumentation and implants for treating degenerative spinal conditions. Its products include PROW FUSION and eSPIN System. The company was founded in 2006 by Didier Toubia and Tzony Siegal and is headquartered in Kfar Saba, Israel. | Medical Specialties | Director/Board Member Director/Board Member | |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman Director of Finance/CFO | |
Inotrem SA
Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Masters Business Admin | |
Sciences Po | College/University | Undergraduate Degree Graduate Degree | |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Stanford Graduate School of Business | College/University | Graduate Degree Masters Business Admin | |
Walor International SAS
Walor International SAS Metal FabricationProducer Manufacturing Walor International SAS manufactures precision machine components for the automotive industry. Its expertise includes cold forging, machining, and thermal treatment. The company was founded by Jacky Lorin and Jim Wallart in June 1993 and is headquartered in Lege, France. | Metal Fabrication | Director/Board Member Director/Board Member | |
HEC Montréal | College/University | Undergraduate Degree Undergraduate Degree | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Founder | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Université Paris Nanterre | College/University | Graduate Degree Graduate Degree | |
Imperial College London | College/University | Graduate Degree Masters Business Admin | |
Ellisphère SAS
Ellisphère SAS Data Processing ServicesTechnology Services Ellisphère SAS develops and provides data science and analytics solutions. It specializes in the collection and processing of financial, economic, and legal information for investment professional. The company was founded in 2006 and is headquartered in Nanterre, France. | Data Processing Services | Director/Board Member Director/Board Member | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
G3S Alyzia SAS
G3S Alyzia SAS Financial ConglomeratesFinance G3s Alyzia SASU operates as a holding company with interests in facility management and cleaning services. The company is headquartered in Ramonville-Saint-Agne, France. | Financial Conglomerates | Director/Board Member Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Director/Board Member Private Equity Investor | |
Passman SAS
Passman SAS Information Technology ServicesTechnology Services Passman SASU manufactures and designs digital solutions and telecommunication appliances. The firm's products include Wi-Fi access device, web corner, touch screen tablet, and electronic signage. The company was founded by Patrick Layani and Frederic Levy Valensi in 1995 and is headquartered in Villeurbanne, France. | Information Technology Services | Director/Board Member Director/Board Member |
Statistics
International
France | 18 |
United Kingdom | 10 |
United States | 8 |
Netherlands | 7 |
Israel | 3 |
Sectoral
Health Technology | 22 |
Consumer Services | 19 |
Technology Services | 4 |
Finance | 4 |
Commercial Services | 3 |
Operational
Director/Board Member | 479 |
Corporate Officer/Principal | 117 |
Private Equity Investor | 78 |
Chairman | 76 |
Chief Executive Officer | 69 |
Most connected contacts
Insiders | |
---|---|
Pierre Legault | 45 |
Barbara Dalton | 35 |
Chen-Ming Yu | 33 |
Martijn Kleijwegt | 33 |
Brent Ahrens | 30 |
René Kuijten | 30 |
Iain Dukes | 30 |
Moshe Arkin | 29 |
Ron Hunt | 29 |
Rémi Droller | 29 |
Raymond Cohen | 28 |
Michael Carter | 22 |
Edward L. Erickson | 20 |
Jonathan Leslie Tobin | 19 |
Gilles Nobécourt | 19 |
- Stock Market
- Insiders
- Raphaël Wisniewski
- Company connections